The global cardiology market is expected to grow at a CAGR of around 8.8% from 2020 to 2027 and projected to reach the market value of around US$ 24.3 Bn by 2027.
Cardiology is a medical specialty and a branch of internal medicine intended to diagnose disorders of the heart in a patient’s body. It deals with treatment related to congenital heart defects, coronary artery disease, electrophysiology, heart failure, and valvular heart disease. Sub-specialty of the cardiology field involves cardiac physiology echocardiography, interventional cardiology, and nuclear cardiology.
Market Dynamics
Big calls for "Digital health in general cardiology"
According to the European Society of Cardiology, three major pillars of digital health are telemedicine, smart phone apps, and wearable sensors. These domains of e-health have developed quickly over the past few years but got accelerated during the COVID-19 pandemic. E-Health ECG portable devices act as well suited devices for ECG monitoring aiming to document symptoms such as syncope and palpitations. Additionally, patch ECG monitoring allows recording within 14 days and external loop recorders store ECG segments of fixed duration. Smartphone and smart watches applications detect and classify rthym as regular or irregular. Moreover, by utility of telemedicine in heart failure patients that comprises of non-invasive and invasive home measuring devices to transfer vital parameters from the patient's home to care givers. These tools strongly support the conventional care service to the outpatient clinics or cardiology practice rather than face-to-face contact. Furthermore, through integration of new technologies specifically to novel ethical issues related to data quality, patient-physician relationship, equity of access to healthcare services, and implementation of artificial intelligence (AI). Such a major shift towards digital health will gain huge prominence in the coming years.
Wait, how cell transplantation assist in repairing injured myocardium?
Despite the recent advances in the treatment of acute myocardial infarction, the ability to repair extensive myocardial damage is limited. Current treatment for acute myocardial infarction and subsequent heart failure involves mechanical support using ventricular assist devices, and ultimate cardiac transplantation. However, these treatments have limitations such as rejection, infection, and organ donor shortages. Cell transplantation will open new doors coupled with enormous potential to repair or regenerate the injured myocardium in the patient’s body. Cellular cardiomyoplasty (Cell transplantation for cardiac repair) has been attempted with several types of cells involving fetal cardiomyocytes, autologous skeletal myoblasts, adult cardiac-derived cells, embryonic stem cells, and bone marrow stem cells. These cell types have shown promising results in animal studies among that skeletal myoblasts have been the first choice by the researchers to be evaluated in clinical settings.
Medical technology: Top investment pocket for cardiology market
Innovations in technology for treatment of heart diseases offer lucrative opportunities for the growth of global cardiology market. Involvement of miniature ventricular assist device (VAD) is gaining high prominence in the global patient care supported for advanced heart failures. By incorporating VAD it has shown promising results for improving the quality of life and act as an alternative in donor heart shortages for patient care. Supportive innovations by improvement in device size, battery reliability, and even wireless charging technologies make this device gain attention in the worldwide market in the coming years and decrease patient susceptibility to infections. Also, novel device based technologies supported for prevention of stroke have evolved rapidly. There has been a strong focus of the companies towards development of newer devices such as carotid implants, these devices are designed for continuous embolic filtration at the level of the common aortic pathway. These devices are currently being tested in preclinical studies and will provide a new gateway as a treatment option for patients suffering from bleeding associated problems. Such technological innovations supported by medical devices enhance the growth of global cardiology market. Also, several devices have been developed to provide other advanced measures for circulatory support. Through incorporation of extracorporeal oxygenation (ECMO), it offers patients the opportunity to avoid mechanical ventilation. This helps to possible decrease blood pressure anesthesia and reduction in venous return. Currently, there is a high focus on the development of small portable devices aiming to offer ventilator circulatory support for critical cases.
Segmental Analysis
The global cardiology market is segmented based on disease indication, medical devices, drug type, and by distribution channel. By disease indication, the market is segmented based on hypertension, hyperlipidemia, arrhythmia, and others. By medical devices, it is further segmented as pacemakers, implantable cardioverter defibrillators (ICDs), ventricular assist devices (VAD), cardiac resynchronization therapy (CRT) devices, heart monitors, stents, catheters, and others. Further, by drug type, it is segmented as antihypertensive, antihyperlipidemic, anticoagulants, antiplatelet drugs, and others. By distribution channel, the market is segmented as hospital pharmacies, retail pharmacies, and online pharmacies.
Based on disease indication, hypertension segment is expected to grow faster and record significant CAGR in the coming years. This is attributed to rising prevalence of hypertension across the world. According to the statistics revealed by the Centre of Disease Control and Prevention (CDC), in 2018, nearly half of a million deaths in the US involve hypertension as a primary contributor. Moreover, about 1 in 4 adults (24%) with hypertension among adult population have their condition under control. Critical cardiovascular diseases involving coronary artery diseases considered as a seriously threatening cardiovascular condition also severely impact for myocardial infarctions. Based on drugs, anticoagulant drugs are anticipated to generate dominant share in the forecast period. Anticoagulants are expensive drugs that assist in critical cases and considered as a strong drug category for patient suffering from myocardial infarctions. Anticoagulants possess chemical substance that intends to reduce coagulation of blood and prolong the blood clotting time. These drugs are majorly preferable for critical cases involving high risk blood clots in several medical conditions such as atrial fibrillation, deep vein thrombosis, myocardial infarction, pulmonary embolism, stroke, and others.
Regional Overview
Based on regions, North America dominates the cardiology market from the past and will continue similar trend in the forthcoming years. Large base of patient pool suffering from cardiovascular diseases and new product launches across the region are the prominent factors that have positive influence on the growth of the market. Apart from that, rising research and development activities initiatives and rising awareness regarding treatment of cardiovascular diseases.
Competitive Landscape
Prominent players involved in cardiology market involve Medtronic plc, Boston Scientific Corporation, Abbott Laboratories, Edwards Lifesciences, Cardinal Health, Terumo Corporation, Biosensors International Group, and among others
Market Segmentation
Market By Disease Indication
Hypertension
Hyperlipidemia
Arrhythmia
Others
Market By Medical Devices
Pacemakers
Implantable Cardioverter Defibrillators (ICDs)
Ventricular Assist Devices (VAD)
Cardiac Resynchronization Therapy (CRT) Devices
Heart Monitors
Stents
Catheters
Others
Market By Drug Type
Antihypertensive
Antihyperlipidemic
Anticoagulants
Antiplatelet drugs
Others
Market By Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Market By Geography
North America
• U.S.
• Canada
Europe
• U.K.
• Germany
• France
• Spain
• Rest of Europe
Asia-Pacific
• China
• Japan
• India
• Australia
• South Korea
• Rest of Asia-Pacific
Latin America
• Brazil
• Mexico
• Rest of Latin America
Middle East & Africa
• GCC
• South Africa
• Rest of Middle East & Africa
CHAPTER 1. Industry Overview of Cardiology
1.1. Definition and Scope
1.1.1. Definition of Cardiology
1.1.2. Market Segmentation
1.1.3. Years Considered for the Study
1.1.4. Assumptions and Acronyms Used
1.1.4.1. Market Assumptions and Market Forecast
1.1.4.2. Acronyms Used in Global Cardiology Market
1.2. Summary
1.2.1. Executive Summary
1.2.2. Cardiology Market By Disease Indication
1.2.3. Cardiology Market By Medical Devices
1.2.4. Cardiology Market By Drug Type
1.2.5. Cardiology Market By Distribution Channel
1.2.6. Cardiology Market by Regions
CHAPTER 2. Research Approach
2.1. Methodology
2.1.1. Research Programs
2.1.2. Market Size Estimation
2.1.3. Market Breakdown and Data Triangulation
2.2. Data Source
2.2.1. Secondary Sources
2.2.2. Primary Sources
CHAPTER 3. Market Dynamics And Competition Analysis
3.1. Market Drivers
3.1.1. Driver 1
3.1.2. Driver 2
3.2. Restraints and Challenges
3.2.1. Restrain 1
3.2.2. Restrain 2
3.3. Growth Opportunities
3.3.1. Opportunity 1
3.3.2. Opportunity 2
3.4. Porter’s Five Forces Analysis
3.4.1. Bargaining Power of Suppliers
3.4.2. Bargaining Power of Buyers
3.4.3. Threat of Substitute
3.4.4. Threat of New Entrants
3.4.5. Degree of Competition
3.5. Regulatory Compliance
3.6. Competitive Landscape, 2019
3.6.1. Player Positioning Analysis
3.6.2. Key Strategies Adopted By Leading Players
CHAPTER 4. Cardiology Market By Disease Indication
4.1. Introduction
4.2. Cardiology Revenue By Disease Indication
4.2.1. Cardiology Revenue (US$ Mn) and Forecast, By Disease Indication, 2016-2027
4.2.2. Hypertension
4.2.2.1. Hypertension Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
4.2.3. Hyperlipidemia
4.2.3.1. Hyperlipidemia Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
4.2.4. Arrhythmia
4.2.4.1. Arrhythmia Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
4.2.5. Others
4.2.5.1. Others Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
CHAPTER 5. Cardiology Market Revenue By Medical Devices
5.1. Introduction
5.2. Cardiology Revenue (US$ Mn) By Medical Devices
5.2.1. Cardiology Revenue (US$ Mn) and Forecast By Medical Devices, 2016 - 2027
5.2.2. Pacemakers
5.2.2.1. Pacemakers Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
5.2.3. Implantable Cardioverter Defibrillators (ICDs)
5.2.3.1. Implantable Cardioverter Defibrillators (ICDs) Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
5.2.4. Ventricular Assist Devices (VAD)
5.2.4.1. Ventricular Assist Devices (VAD) Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
5.2.5. Cardiac Resynchronization Therapy (CRT) Devices
5.2.5.1. Cardiac Resynchronization Therapy (CRT) Devices Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
5.2.6. Heart Monitors
5.2.6.1. Heart Monitors Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
5.2.7. Stents
5.2.7.1. Stents Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
5.2.8. Catheters
5.2.8.1. Catheters Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
5.2.9. Others
5.2.9.1. Others Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
CHAPTER 6. Cardiology Market By Drug Type
6.1. Introduction
6.2. Cardiology Revenue (US$ Mn) By Drug Type
6.2.1. Cardiology Revenue (US$ Mn) and Forecast By Drug Type, 2016 - 2027
6.2.2. Antihypertensive
6.2.2.1. Antihypertensive Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
6.2.3. Antihyperlipidemic
6.2.3.1. Antihyperlipidemic Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
6.2.4. Anticoagulants
6.2.4.1. Anticoagulants Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
6.2.5. Antiplatelet drugs
6.2.5.1. Antiplatelet drugs Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
6.2.6. Others
6.2.6.1. Others Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
CHAPTER 7. Cardiology Market By Distribution Channel
7.1. Introduction
7.2. Cardiology Revenue (US$) By Distribution Channel
7.2.1. Cardiology Revenue (US$ Mn) and Forecast By Distribution Channel, 2016 - 2027
7.3. Hospital Pharmacies
7.3.1. Hospital Pharmacies Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
7.4. Retail Pharmacies
7.4.1. Retail Pharmacies Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
7.5. Online Pharmacies
7.5.1. Online Pharmacies Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
CHAPTER 8. North America Cardiology Market By Country
8.1. North America Cardiology Overview
8.2. U.S.
8.2.1. U.S. Cardiology Market Revenue (US$ Mn) and Forecast By Disease Indication, 2016-2027
8.2.2. U.S. Cardiology Market Revenue (US$ Mn) and Forecast By Medical Devices, 2016-2027
8.2.3. U.S. Cardiology Market Revenue (US$ Mn) and Forecast By Drug Type, 2016-2027
8.2.4. U.S. Cardiology Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2016-2027
8.3. Canada
8.3.1. Canada Cardiology Market Revenue (US$ Mn) and Forecast By Disease Indication, 2016-2027
8.3.2. Canada Cardiology Market Revenue (US$ Mn) and Forecast By Medical Devices, 2016-2027
8.3.3. Canada Cardiology Market Revenue (US$ Mn) and Forecast By Drug Type, 2016-2027
8.3.4. Canada Cardiology Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2016-2027
8.4. North America PEST Analysis
CHAPTER 9. Europe Cardiology Market By Country
9.1. Europe Cardiology Market Overview
9.2. U.K.
9.2.1. U.K. Cardiology Market Revenue (US$ Mn) and Forecast By Disease Indication, 2016-2027
9.2.2. U.K. Cardiology Market Revenue (US$ Mn) and Forecast By Medical Devices, 2016-2027
9.2.3. U.K. Cardiology Market Revenue (US$ Mn) and Forecast By Drug Type, 2016-2027
9.2.4. U.K. Cardiology Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2016-2027
9.3. Germany
9.3.1. Germany Cardiology Market Revenue (US$ Mn) and Forecast By Disease Indication, 2016-2027
9.3.2. Germany Cardiology Market Revenue (US$ Mn) and Forecast By Medical Devices, 2016-2027
9.3.3. Germany Cardiology Market Revenue (US$ Mn) and Forecast By Drug Type, 2016-2027
9.3.4. Germany Cardiology Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2016-2027
9.4. France
9.4.1. France Cardiology Market Revenue (US$ Mn) and Forecast By Disease Indication, 2016-2027
9.4.2. France Cardiology Market Revenue (US$ Mn) and Forecast By Medical Devices, 2016-2027
9.4.3. France Cardiology Market Revenue (US$ Mn) and Forecast By Drug Type, 2016-2027
9.4.4. France Cardiology Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2016-2027
9.5. Spain
9.5.1. Spain Cardiology Market Revenue (US$ Mn) and Forecast By Disease Indication, 2016-2027
9.5.2. Spain Cardiology Market Revenue (US$ Mn) and Forecast By Medical Devices, 2016-2027
9.5.3. Spain Cardiology Market Revenue (US$ Mn) and Forecast By Drug Type, 2016-2027
9.5.4. Spain Cardiology Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2016-2027
9.6. Rest of Europe
9.6.1. Rest of Europe Cardiology Market Revenue (US$ Mn) and Forecast By Disease Indication, 2016-2027
9.6.2. Rest of Europe Cardiology Market Revenue (US$ Mn) and Forecast By Medical Devices, 2016-2027
9.6.3. Rest of Europe Cardiology Market Revenue (US$ Mn) and Forecast By Drug Type, 2016-2027
9.6.4. Rest of Europe Cardiology Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2016-2027
9.7. Europe PEST Analysis
CHAPTER 10. Asia Pacific Cardiology Market By Country
10.1. Asia Pacific Cardiology Market Overview
10.2. China
10.2.1. China Cardiology Market Revenue (US$ Mn) and Forecast By Disease Indication, 2016 - 2027
10.2.2. China Cardiology Market Revenue (US$ Mn) and Forecast By Medical Devices, 2016 - 2027
10.2.3. China Cardiology Market Revenue (US$ Mn) and Forecast By Drug Type, 2016 - 2027
10.2.4. China Cardiology Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2016 - 2027
10.3. Japan
10.3.1. Japan Cardiology Market Revenue (US$ Mn) and Forecast By Disease Indication, 2016 - 2027
10.3.2. Japan Cardiology Market Revenue (US$ Mn) and Forecast By Medical Devices, 2016 - 2027
10.3.3. Japan Cardiology Market Revenue (US$ Mn) and Forecast By Drug Type, 2016 - 2027
10.3.4. Japan Cardiology Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2016 - 2027
10.4. India
10.4.1. India Cardiology Market Revenue (US$ Mn) and Forecast By Disease Indication, 2016 - 2027
10.4.2. India Cardiology Market Revenue (US$ Mn) and Forecast By Medical Devices, 2016 - 2027
10.4.3. India Cardiology Market Revenue (US$ Mn) and Forecast By Drug Type, 2016 - 2027
10.4.4. India Cardiology Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2016 - 2027
10.5. Australia
10.5.1. Australia Cardiology Market Revenue (US$ Mn) and Forecast By Disease Indication, 2016 - 2027
10.5.2. Australia Cardiology Market Revenue (US$ Mn) and Forecast By Medical Devices, 2016 - 2027
10.5.3. Australia Cardiology Market Revenue (US$ Mn) and Forecast By Drug Type, 2016 - 2027
10.5.4. Australia Cardiology Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2016 - 2027
10.6. South Korea
10.6.1. South Korea Cardiology Market Revenue (US$ Mn) and Forecast By Disease Indication, 2016 - 2027
10.6.2. South Korea Cardiology Market Revenue (US$ Mn) and Forecast By Medical Devices, 2016 - 2027
10.6.3. South Korea Cardiology Market Revenue (US$ Mn) and Forecast By Drug Type, 2016 - 2027
10.6.4. South Korea Cardiology Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2016 - 2027
10.7. Rest of Asia-Pacific
10.7.1. Rest of Asia-Pacific Cardiology Market Revenue (US$ Mn) and Forecast By Disease Indication, 2016 - 2027
10.7.2. Rest of Asia-Pacific Cardiology Market Revenue (US$ Mn) and Forecast By Medical Devices, 2016 - 2027
10.7.3. Rest of Asia-Pacific Cardiology Market Revenue (US$ Mn) and Forecast By Drug Type, 2016 - 2027
10.7.4. Rest of Asia-Pacific Cardiology Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2016 - 2027
10.8. Asia Pacific PEST Analysis
CHAPTER 11. Latin America Cardiology Market By Country
11.1. Latin America Cardiology Market Overview
11.2. Brazil
11.2.1. Brazil Cardiology Market Revenue (US$ Mn) and Forecast By Disease Indication, 2016 - 2027
11.2.2. Brazil Cardiology Market Revenue (US$ Mn) and Forecast By Medical Devices, 2016 - 2027
11.2.3. Brazil Cardiology Market Revenue (US$ Mn) and Forecast By Drug Type, 2016 - 2027
11.2.4. Brazil Cardiology Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2016 - 2027
11.3. Mexico
11.3.1. Mexico Cardiology Market Revenue (US$ Mn) and Forecast By Disease Indication, 2016 - 2027
11.3.2. Mexico Cardiology Market Revenue (US$ Mn) and Forecast By Medical Devices, 2016 - 2027
11.3.3. Mexico Cardiology Market Revenue (US$ Mn) and Forecast By Drug Type, 2016 - 2027
11.3.4. Mexico Cardiology Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2016 - 2027
11.4. Rest of Latin America
11.4.1. Rest of Latin America Cardiology Market Revenue (US$ Mn) and Forecast By Disease Indication, 2016 - 2027
11.4.2. Rest of Latin America Cardiology Market Revenue (US$ Mn) and Forecast By Medical Devices, 2016 - 2027
11.4.3. Rest of Latin America Cardiology Market Revenue (US$ Mn) and Forecast By Drug Type, 2016 - 2027
11.4.4. Rest of Latin America Cardiology Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2016 - 2027
CHAPTER 12. Middle East & Africa Cardiology Market By Country
12.1. Middle East & Africa Cardiology Market Overview
12.2. Saudi Arabia
12.2.1. Saudi Arabia Cardiology Market Revenue (US$ Mn) and Forecast By Disease Indication, 2016 - 2027
12.2.2. Saudi Arabia Cardiology Market Revenue (US$ Mn) and Forecast By Medical Devices, 2016 - 2027
12.2.3. Saudi Arabia Cardiology Market Revenue (US$ Mn) and Forecast By Drug Type, 2016 - 2027
12.2.4. Saudi Arabia Cardiology Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2016 - 2027
12.3. UAE
12.3.1. UAE Cardiology Market Revenue (US$ Mn) and Forecast By Disease Indication, 2016 - 2027
12.3.2. UAE Cardiology Market Revenue (US$ Mn) and Forecast By Medical Devices, 2016 - 2027
12.3.3. UAE Cardiology Market Revenue (US$ Mn) and Forecast By Drug Type, 2016 - 2027
12.3.4. UAE Cardiology Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2016 - 2027
12.4. Rest of Middle East & Africa
12.4.1. Rest of Middle East & Africa Cardiology Market Revenue (US$ Mn) and Forecast By Disease Indication, 2016 - 2027
12.4.2. Rest of Middle East & Africa Cardiology Market Revenue (US$ Mn) and Forecast By Medical Devices, 2016 - 2027
12.4.3. Rest of Middle East & Africa Cardiology Market Revenue (US$ Mn) and Forecast By Drug Type, 2016 - 2027
12.4.4. Rest of Middle East & Africa Cardiology Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2016 - 2027
CHAPTER 13. Player Analysis Of Cardiology
13.1. Cardiology Market Company Share Analysis
13.2. Competition Matrix
13.2.1. Competitive Benchmarking of key players by price, presence, market share, and R&D investment
13.2.2. New Product Launches and Product Enhancements
13.2.3. Mergers And Acquisition In Global Cardiology Market
13.2.4. Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements
CHAPTER 14. Company Profile
14.1. Medtronic plc
14.1.1. Company Snapshot
14.1.2. Business Overview
14.1.3. Financial Overview
14.1.3.1. Revenue (US$ Mn), 2019
14.1.3.2. Medtronic plc 2019 Cardiology Business Regional Distribution
14.1.4. Product/ Service and Specification
14.1.5. Recent Developments & Business Strategy
14.1.6. Manufacturing Plant Footprint Analysis
14.2. Boston Scientific Corporation
14.3. Abbott Laboratories
14.4. Edwards Lifesciences
14.5. Cardinal Health
14.6. Terumo Corporation
14.7. Biosensors International Group
14.8. Others
